Side effects from stopping Adderall and starting Vyvanse Adderall and Vyvanse are both stimulant medications, so they share similar potential side effects
Good Great experience
Ive lost 15lbs within 3 weeks and ready to lose more
Injectable GLP-1 medications currently have a stronger and more established evidence base for weight loss, but oral options are showing meaningful results in clinical trials: In the head-to-head SURMOUNT-5 trial, researchers reported injectable tirzepatide had a mean weight reduction of about 20.2% at 72 weeks, compared with roughly 13.7% for injectable semaglutide
We Understand GLP-1RAs: We have already been engaged by several clients to advise them on the potential impact of GLP-1RAs on their business
The consensus, available here, amends the earlier guidance on liraglutide (Saxenda) and semaglutide (Wegovy) use (previously in specialist weight management services only), and will also apply to tirzepatide (Mounjaro), for which guidance was not previously in place